Aromatic sulfone hydroxamates and their use of protease inhibitors

Aromatic sulfone hydroxamates and their use of protease inhibitors

This invention is directed to aromatic sulfone hydroxamic acids (including hydroxamates) and salts thereof that, inter alia, inhibit matrix metalloproteinase (also known as "matrix metalloprotease" or "MMP") activity and/or aggrecanase activity. This invention also is directed to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YVETTE M FOBIAN, DARREN J KASSAB, TERRI L BOEHM, GARY A DE CRESCENZO, LOUIS J BEDELL, JOSEPH G RICO, DANIEL P BECKER, CLARA I VILLAMIL, LIJUAN JANE WANG, STEPHEN A KOLODZIEJ, JOHN JEFFREY TALLEY, DEBORAH A MISCHKE, JEFFERY N CARROLL, JOHN N FRESKOS, SUSAN L HOCKERMAN, MONICA NORTON, THOMAS E BARTA, JOSEPH J MCDONALD
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This invention is directed to aromatic sulfone hydroxamic acids (including hydroxamates) and salts thereof that, inter alia, inhibit matrix metalloproteinase (also known as "matrix metalloprotease" or "MMP") activity and/or aggrecanase activity. This invention also is directed to a prevention or treatment method that comprises administering such a compound or salt in an MMP-inhibiting and/or aggrecanase-inhibiting effective amount to an animal, particularly a mammal having (or disposed to having) a pathological condition associated with MMP and/or aggrecanase activity.